Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate

Yu Teranishi^{1

2}, Andrey Yurchenko³, Suzanne Tran^{1

4}, Philipp Sievers^{5

6}, Fatemeh Rajabi³, Singhabahu Ruchith⁷, Samiya Abi-Jaoude¹, Antoine Blouin¹, Franck Bielle^{1

4}, Dominique Cazals-Hatem⁸, Felix Sahm^{5

6}, Sergey Nikolaev³, Michel Kalamarides^{1

2}, Matthieu Peyre^{9

10}

Affiliations

¹ Institut du Cerveau et de la Moelle Epinière, Sorbonne Université, CRICM INSERM U1127 CNRS UMR 7225,, 75013, Paris, France.
² Department of Neurosurgery, AP-HP, Hôpital Pitié-Salpêtrière, 47-91 bvd de l'Hopital, 75013, Paris, France.
³ Translational Cancer Genomics Lab, B2M, Gustave Roussy, INSERM U981, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France.
⁴ Department of Neuropathology, AP-HP, Hôpital Pitié Salpétrière, 75013, Paris, France.
⁵ Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
⁶ Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
⁷ Alztheimer's Disease and Prion Diseases, Paris Brain Institute, Paris, France.
⁸ Department of Neuropathology, AP-HP, Hôpital Beaujon, 92100, Clichy, France.
⁹ Institut du Cerveau et de la Moelle Epinière, Sorbonne Université, CRICM INSERM U1127 CNRS UMR 7225,, 75013, Paris, France. matthieu.peyre@aphp.fr.
¹⁰ Department of Neurosurgery, AP-HP, Hôpital Pitié-Salpêtrière, 47-91 bvd de l'Hopital, 75013, Paris, France. matthieu.peyre@aphp.fr.

Yu Teranishi et al. Acta Neuropathol. 2024.

. 2024 Aug 27;148(1):30.

doi: 10.1007/s00401-024-02791-1.

¹ Institut du Cerveau et de la Moelle Epinière, Sorbonne Université, CRICM INSERM U1127 CNRS UMR 7225,, 75013, Paris, France.
² Department of Neurosurgery, AP-HP, Hôpital Pitié-Salpêtrière, 47-91 bvd de l'Hopital, 75013, Paris, France.
³ Translational Cancer Genomics Lab, B2M, Gustave Roussy, INSERM U981, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France.
⁴ Department of Neuropathology, AP-HP, Hôpital Pitié Salpétrière, 75013, Paris, France.
⁵ Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
⁶ Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
⁷ Alztheimer's Disease and Prion Diseases, Paris Brain Institute, Paris, France.
⁸ Department of Neuropathology, AP-HP, Hôpital Beaujon, 92100, Clichy, France.
⁹ Institut du Cerveau et de la Moelle Epinière, Sorbonne Université, CRICM INSERM U1127 CNRS UMR 7225,, 75013, Paris, France. matthieu.peyre@aphp.fr.
¹⁰ Department of Neurosurgery, AP-HP, Hôpital Pitié-Salpêtrière, 47-91 bvd de l'Hopital, 75013, Paris, France. matthieu.peyre@aphp.fr.

No abstract available

References

1. Abi Jaoude S, Peyre M, Degos V, Goutagny S, Parfait B, Kalamarides M (2020) Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients. J Neurosurg 134:1377–1385 - DOI - PubMed
1. Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ et al (2017) Genomic landscape of high-grade meningiomas. Npj Genomic Med. https://doi.org/10.1038/s41525-017-0014-7 - DOI
1. Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG et al (2023) Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med 29(12):3067–3076 - DOI - PubMed - PMC
1. Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649–659 - DOI - PubMed - PMC
1. Clark VE, Harmancı AS, Bai H, Youngblood MW, Lee TI, Baranoski JF et al (2016) Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 48:1253–1259 - DOI - PubMed - PMC